| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(01)00680-3 |
| P698 | PubMed publication ID | 11947896 |
| P2093 | author name string | Duncan J Stewart | |
| Juan Carlos Monge | |||
| Pierre Picard | |||
| Saeid Babaei | |||
| P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
| Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice | Q28584822 | ||
| A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
| Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease | Q33544585 | ||
| Statin trials and goals of cholesterol-lowering therapy after AMI. | Q33699888 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes | Q34172169 | ||
| Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis | Q34541589 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| Infection as a risk factor for infarction and atherosclerosis | Q36845622 | ||
| Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. | Q37365303 | ||
| A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice | Q37377448 | ||
| Autohaemotherapy after treatment of blood with ozone. A reappraisal | Q40705119 | ||
| Interleukin-6 exacerbates early atherosclerosis in mice | Q40793841 | ||
| Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation | Q40848870 | ||
| The genetic basis of atherosclerosis | Q41465052 | ||
| Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis | Q41615081 | ||
| Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials | Q47675542 | ||
| C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction | Q47974191 | ||
| New insights into plaque stabilisation by lipid lowering. | Q52531869 | ||
| Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
| Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma | Q71799262 | ||
| Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis | Q72221719 | ||
| Immune mechanisms in atherosclerosis | Q72495003 | ||
| The effect of VAS972 on allergic contact hypersensitivity | Q72996947 | ||
| Clinical trials of reducing low-density lipoprotein concentrations | Q77452744 | ||
| Treatment challenges in hypercholesterolemia | Q77588751 | ||
| Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice | Q77995417 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 45-53 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Effects of VasoCare therapy on the initiation and progression of atherosclerosis | |
| P478 | volume | 162 |
| Q24647087 | A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design |
| Q33479570 | Effects of therapy using the Celacade system on structural and functional cardiac remodelling in rats following myocardial infarction |
| Q47968070 | Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial |
| Q37608525 | Targets for immunomodulation in cardiovascular disease--where are we now? |
Search more.